Skip to main content
. 2022 Jul 23;15(8):912. doi: 10.3390/ph15080912
Inline graphic
Inline graphic
Inline graphic
  • Immunosuppressant at high concentration and immunomodulator at low/normal concentration

  • Negatively regulates IL-2 and IFNγ by lymphocytes and TNF-α and IL-12 by macrophages

  • Reduced immune-inflammatory responses

  • Activates Sirt1 which negatively interferes with the TLR4/NF-κB/STAT signal, with reduced cytokines secretion from inactivated immune cells and macrophage/mast cell-derived pro-inflammatory factors.

  • Activates macrophages, T cells, and NK cells

  • Regulates CD4+CD25+ regulatory T cell suppressive functions

  • Activates Sirt1 which deacetylates STAT3 interfering with th17 lymphocyte differentiation

  • Restores T-cell function targeting the immune-checkpoint signaling PD-1/PD-L1

  • Activates NK cells through AKT- and mTORC2-mediated c-Myb upregulation

  • Mostly immunosuppressant but immunomodulator in the elderly

  • Provides general inhibitory effects on the immune system

  • Ameliorates some immune functions in the elderly, response to vaccination and improved outcomes from infections

  • Inactivates T and B lymphocytes

  • Impairs lipid to glucose metabolism and immune suppression in long-term use

  • Extends lifespan and delay aging in model organisms

  • Reduces p16INK4A protein expression and increases collagen VII protein levels in the skin

  • Reduces the negative effects on the immune system in COVID-19 patients

  • ostly immunomodulator

  • Exerts direct immunomodulatory effect on immune cells by AMPK induction and mTORC1 inhibition

  • Promotes health immunity via an H3K4 methyltransferase/demethylase complex, downregulating some targets, including mTOR and S6 kinase

  • Increases the differentiation of naïve T cells into both regulatory and memory T cells, while decreasing the ability of neutrophils to initiate in NETosis.

  • Exerts immunomodulatory effects and contributes to the reduction of lung metastases of melanoma cell

  • Increases the number and function of tumor-infiltrating lymphocytes (TILs) and inhibits oxidative phosphorylation in B cells

  • Reduces the stability and localization of PD-L1

  • Contributes to the improvement of CTLs against cancer cells

  • Reduces the burden of autoimmune diseases in several animal models and some human studies